Table 5.
Treatment regimen and number of treatment courses administered in CVID+EGD group.
| Treatment regimens in CVID+EGD | Total | Treatment courses with remission | Treatment courses without remission |
|---|---|---|---|
| steroids | 21 | 18 (85.7%) | 3 (14.3%) |
| IgRT | 6 | 3 (50%) | 3 (50%) |
| infliximab | 6 | 6 (100%) | 0 (0%) |
| steroids with IgRT | 4 | 4 (100%) | 0 (0%) |
| etanercept | 3 | 3 (100%) | 0 (0%) |
| anti-mycobacterial therapy | 1 | 0 (0%) | 1 (100%) |
| adalimumab | 1 | 0 (0%) | 1 (100%) |
| antibiotics with steroids | 1 | 0 (0%) | 1 (100%) |
| antibiotics, anti-fungal therapy, steroids, cyclosporine, hydroxychloroquine, IFN-γ, MTX | 1 | 0 (0%) | 1 (100%) |
| cyclophosphamide | 1 | 1 (100%) | 0 (0%) |
| cyclosporine | 1 | 1 (100%) | 0 (0%) |
| IFN-alpha with anti-mycobacterial therapy | 1 | 1 (100%) | 0 (0%) |
| MMF | 1 | 1 (100%) | 0 (0%) |
| steroids with anti-mycobacterial therapy | 1 | 0 (0%) | 1 (100%) |
| steroids with azathioprine | 1 | 1 (100%) | 0 (0%) |
| steroids with infliximab | 1 | 0 (0%) | 1 (100%) |
| steroids with methotrexate | 1 | 1 (100%) | 0 (0%) |
| steroids with rituximab | 1 | 1 (100%) | 0 (0%) |
| Total | 53 | 41 | 12 |
IgRT, immunoglobulin replacement therapy; IFN, interferon; MTX, methotrexate; MMF, mycophenolate mofetil. Percentages are of total number of treatment courses per treatment regimen.